Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Artiva Biotherapeutics
Biotech
Artiva upsizes IPO to $167 million
The biotech has knocked its share price down to $12, but raised the number of shares on offer to 13.9 million.
James Waldron
Jul 19, 2024 4:56am
Artiva sets out $135M IPO to push NK cell therapy through trials
Jul 15, 2024 8:33am
Artiva plans IPO to fund NK cell therapy's autoimmune trials
Jul 1, 2024 7:48am
AACR: New Affimed data disappoints after Nasdaq flags stock dip
Apr 17, 2023 12:52pm
Forte taps new exec amid shareholder dissent—Chutes & Ladders
Jun 10, 2022 9:30am
Merck NK cell ally Artiva splashes out on new digs in San Diego
Aug 12, 2021 9:35am
